Cargando…

Induction of Cytotoxic T Lymphocytes from Peripheral Blood of Human Histocompatibility Antigen (HLA)‐A31(+) Gastric Cancer Patients by in vitro Stimulation with Antigenic Peptide of Signet Ring Cell Carcinoma

Antigenic peptides have been used as a cancer vaccine in melanoma patients and have led to a drastic regression of metastatic tumors. However, few antigens have been identified in non‐melanoma tumors. We recently purified a new natural antigenic peptide, designated F4.2, by biochemical elution from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nabeta, Yuki, Sahara, Hiroeki, Suzuki, Kazuhiro, Kondo, Hiroaki, Nagata, Masami, Hirohashi, Yoshihiko, Sato, Yuriko, Wada, Yoshimasa, Sato, Takashi, Wada, Takuro, Yamashita, Toshihiko, Kikuchi, Kokichi, Sato, Noriyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926399/ https://www.ncbi.nlm.nih.gov/pubmed/10874214 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00990.x

Ejemplares similares

Natural Antigenic Peptides from Squamous Cell Carcinoma Recognized by Autologous HLA‐DR8–restricted CD4(+) T Cells
por: Kondo, Hiroaki, et al.
Publicado: (2002)

Cellular Stress‐ and Transformation‐associated Cell Surface Antigens Expressed on Human and Rodent Tumor Cells
por: Torigoe, Toshihiko, et al.
Publicado: (1993)

Identification of a Human T Cell Clone with the Cytotoxic T Lymphocyte and Natural Killer‐like Cytotoxic Function against Autologous Mammary Carcinoma and K562 Line
por: Sato, Takashi, et al.
Publicado: (1989)

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
por: Tsukahara, Tomohide, et al.
Publicado: (2009)

A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

T‐Cell Receptor Gene Structures of HLA‐A26‐restricted Cytotoxic T Lymphocyte Lines against Human Autologous Pancreatic Adenocarcinoma
por: Ueda, Daisuke, et al.
Publicado: (1995)

The Expression of Tumor Rejection Antigen on Rat Fetus Fibroblasts Transformed by the ras Oncogene
por: Okubo, Mamoru, et al.
Publicado: (1988)

Cytotoxicity of Histocompatibility Leukocyte Antigen–DR8–restricted CD4(+) Killer T Cells against Human Autologous Squamous Cell Carcinoma
por: Miyazaki, Akihiro, et al.
Publicado: (1997)

Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules
por: Sahara, Hiroeki, et al.
Publicado: (2003)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
por: Tadano, Hiroki, et al.
Publicado: (2020)

Detection of Bone‐type Alkaline Phosphatase by Monoclonal Antibodies Reacting with Human Osteosarcoma‐associated Antigen
por: Nagoya, Satoshi, et al.
Publicado: (1991)

Brefeldin A Blocks the Cytotoxicity of T Cell Receptor α/β and γ/δ Cytotoxic T Lymphocyte Clones Reacting against Human Autologous Cancer Cells
por: Wada, Yoshimasa, et al.
Publicado: (1993)

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
por: Kobayashi, Jun-ichi, et al.
Publicado: (2009)

Development of a T‐cell receptor multimer with high avidity for detecting a naturally presented tumor‐associated antigen on osteosarcoma cells
por: Watanabe, Kazue, et al.
Publicado: (2018)

Regulated Expression of Human Histocompatibility Leukocyte Antigen (HLA)-DO During Antigen-dependent and Antigen-independent Phases of B Cell Development
por: Chen, Xinjian, et al.
Publicado: (2002)

Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do
por: van Ham, Marieke, et al.
Publicado: (2000)

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
por: Jäger, Elke, et al.
Publicado: (1998)

Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression
Publicado: (1977)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

Immune responses to human cancer stem‐like cells/cancer‐initiating cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2015)

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996)

In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes
por: Wen, Li, et al.
Publicado: (2000)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA- B35 subtype molecules
Publicado: (1995)

Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.
por: Tomita, Y., et al.
Publicado: (1990)

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice
Publicado: (1994)

Minor Histocompatibility Antigen-Specific T Cells
por: Summers, Corinne, et al.
Publicado: (2020)

Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells
por: Allan, David S.J., et al.
Publicado: (1999)

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
por: Fuchs, Kyra J., et al.
Publicado: (2020)

YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells
por: Tanabe, Atsushi, et al.
Publicado: (2022)

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer
por: Honma, Ichiya, et al.
Publicado: (2009)

Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response
por: Yamashita, Masamichi, et al.
Publicado: (2016)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021)

A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells
por: Rajagopalan, Sumati, et al.
Publicado: (1999)

Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells
por: Münz, Christian, et al.
Publicado: (1997)

The Specificity of Peptides Bound to Human Histocompatibility Leukocyte Antigen (HLA)-B27 Influences the Prevalence of Arthritis in HLA-B27 Transgenic Rats
por: Zhou, Ming, et al.
Publicado: (1998)

THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES
por: Herberman, Ronald, et al.
Publicado: (1965)

Identification of the Lateral Interaction Surfaces of Human Histocompatibility Leukocyte Antigen (HLA)-DM with HLA-DR1 by Formation of Tethered Complexes That Present Enhanced HLA-DM Catalysis
por: Stratikos, Efstratios, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ifo09m4tn57j2d8qjq9lmb3igt